Carboxy-THC (formally called 11-nor-9-carboxy-Δ9-tetrahydrocannabinol, or THC-COOH) is the main marijuana metabolite that drug tests look for in urine, and what counts as a “high” level depends on the context. In federally regulated workplace testing, any confirmed concentration above 15 ng/mL is a positive result, while the initial screening cutoff sits at 50 ng/mL. Heavy, daily cannabis users, though, can produce urine concentrations exceeding 1,000 ng/mL, and levels in the hundreds are common among regular users even days into abstinence. Whether a level is “high” in a meaningful sense depends on who is being tested, how often they use cannabis, and what question the test is trying to answer.
How Carboxy-THC Forms in the Body
When you consume cannabis, the active compound THC enters your bloodstream and is carried to the liver, where enzymes convert most of it into two metabolites. The first is 11-hydroxy-THC, which is psychoactive itself. The second, and the one that matters most for drug testing, is carboxy-THC (THC-COOH), which has no intoxicating effects but lingers in the body far longer than THC itself.1Europe PMC. Mechanisms of Action and Pharmacokinetics of Cannabis Your kidneys gradually filter carboxy-THC and its conjugated forms into urine, which is why urine testing targets this specific metabolite rather than THC directly. Because THC also accumulates in fat tissue and slowly re-enters the bloodstream over days or weeks, your body keeps producing carboxy-THC long after the high has worn off.2Europe PMC. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure
The Standard Cutoffs and What They Mean
Most workplace and forensic drug testing in the United States follows a two-step process. The first step is an immunoassay screening test, and the federal standard cutoff is 50 ng/mL. If the sample hits or exceeds that level, it is sent for confirmatory testing, usually by gas chromatography or liquid chromatography–mass spectrometry, with a confirmation cutoff of 15 ng/mL. A result is only reported as positive when both steps are met. Some testing programs use lower screening thresholds, such as 20 ng/mL, which catches more positives and extends the detection window considerably.
These cutoffs were chosen to minimize false positives from passive exposure or trace residual excretion, not to indicate impairment. A confirmed result above 15 ng/mL tells you that the person has had meaningful exposure to THC. It does not, by itself, tell you when they used cannabis or whether they were impaired at any relevant time.
Typical Concentration Ranges by Frequency of Use
The gap between an occasional user’s carboxy-THC level and a daily user’s level is enormous. A person who smokes once and is tested the next day might produce a urine concentration in the low tens of nanograms per milliliter, potentially not even reaching the 50 ng/mL screening cutoff. A daily, heavy user, by contrast, can show concentrations well above 1,000 ng/mL. One controlled study found that urinary THC-COOH exceeded 1,000 ng/mL for some heavy users as late as 129 hours after their last use.3PubMed Central. Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use
When researchers used creatinine-normalized concentrations (which account for how dilute or concentrated a urine sample is), some chronic users in a monitored abstinence study started with values above 800 ng/mg and were still above 200 ng/mg five days later. In a small percentage of those cases, concentrations stayed elevated and variable for up to 14 days.4Wiley Online Library. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users So when someone asks whether a result of, say, 300 ng/mL is “high,” the honest answer is that it is well above the positive cutoff but entirely typical for a regular user who stopped a few days ago.
How Long Carboxy-THC Stays Detectable
The elimination half-life of carboxy-THC in urine is not a single fixed number. Shorter-term studies have measured mean urinary half-lives around 28 to 32 hours, but when researchers extended the sample collection window to 14 days, they found longer apparent half-lives of roughly 44 to 60 hours.5Lippincott Williams & Wilkins / PubMed Central. Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans This happens because THC-COOH follows a multi-phase elimination pattern: levels drop quickly at first, then taper off slowly as stored THC continues leaking out of fat tissue.
For frequent users, detectable levels can persist for weeks. In one study of adolescent and young adult cannabis users during verified abstinence, the estimated detection window averaged 10 days but ranged from 4 to 80 days. Even after more than 25 days of confirmed abstinence, 40% of participants still had carboxy-THC levels above 5 ng/mL, and about one in five still met the federal positive threshold on combined screening and confirmatory testing.6PubMed Central. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence Another study of chronic daily users found that THC remained detectable in urine for a median of about 7 days, with some participants still testing positive at nearly 25 days.7PubMed Central. Extended Urinary Δ9-Tetrahydrocannabinol Excretion in Chronic Cannabis Users Precludes Use as a Biomarker of New Drug Exposure
In practical terms, if you are a once-a-month user, your levels will likely fall below the 50 ng/mL screening cutoff within a few days. If you use daily, the math changes dramatically, and you could be producing positive specimens for a month or more.
Why Your Levels Can Differ Wildly from Someone Else’s
Two people who smoke the same amount of the same cannabis can produce very different carboxy-THC concentrations in their urine. Several factors drive this variation.
Body fat is one of the most important. THC is fat-soluble, so people with higher body mass index tend to store more of it and release it over a longer period. In a monitored abstinence study, BMI was significantly correlated with how many days it took for urine to test negative.8Oxford Academic. Urinary Elimination of 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol in Cannabis Users During Continuously Monitored Abstinence That same study used creatinine normalization to reduce variability caused by how diluted a person’s urine happened to be at the time of collection. A heavily hydrated person produces dilute urine and may have a lower raw concentration; a dehydrated person’s concentrated sample might look alarmingly high even if the absolute amount of metabolite is similar.
Genetics also play a role. The liver enzyme primarily responsible for converting THC into its metabolites, CYP2C9, comes in several genetic variants. People who carry two copies of the CYP2C9*3 variant produce roughly 70% less carboxy-THC than people with the most common enzyme form, while retaining about three times more THC in their blood.9ResearchGate. Interindividual Variation in the Pharmacokinetics of Δ9-Tetrahydrocannabinol as Related to Genetic Polymorphisms in CYP2C9 In other words, a person with this genotype might stay intoxicated longer but produce lower urine carboxy-THC levels, potentially complicating the interpretation of test results.
Does Exercise or Fasting Affect Your Levels?
Because THC hides in fat cells, it makes intuitive sense that burning fat could release stored THC back into the bloodstream and temporarily raise carboxy-THC levels. Animal research confirmed that lipolysis (fat breakdown triggered by stress or food deprivation) can push THC from fat stores back into the blood.2Europe PMC. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure In one human study, exercise produced a small but statistically significant bump in plasma THC, and the increase was larger in participants with higher BMI.10PubMed Central. Exercise increases plasma THC concentrations in regular cannabis users
However, a separate human study looking specifically at whether exercise or food deprivation could alter cannabinoid levels enough to affect drug test interpretation found no major changes in serum or urine concentrations, concluding that the effect is unlikely to cause a false positive or meaningfully alter results.11PubMed Central. Can physical exercise or food deprivation cause release of fat-stored cannabinoids? The practical takeaway is that the effect exists but is small enough that exercising before a test is unlikely to push you over a cutoff you would not have exceeded anyway.
Can Passive Exposure Produce High Levels?
This is one of the most common questions people have after testing positive, and the research is fairly clear. Extreme secondhand cannabis smoke exposure in an unventilated room can produce detectable carboxy-THC in a non-smoker’s urine, but the levels are generally low and short-lived. In a controlled study, non-smokers exposed to heavy smoke in an unventilated space had maximum urine THC-COOH concentrations ranging from about 1 to 58 ng/mL. Only one specimen hit the 50 ng/mL screening cutoff, while several tested positive at the lower 20 ng/mL threshold.12Oxford University Press. Non-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results Positives were limited to the hours immediately after exposure and only occurred when the smoke exposure was obvious to everyone in the room.
When the same experiment was repeated with ventilation, blood cannabinoid levels in the non-smokers were much lower, and no urine specimens tested positive even at 20 ng/mL.13PubMed Central. Non-Smoker Exposure to Secondhand Cannabis Smoke II: Effect of Room Ventilation on the Physiological, Subjective, and Behavioral/Cognitive Effects A result above 100 ng/mL is essentially impossible from passive exposure alone. If your carboxy-THC is in the hundreds, secondhand smoke is not a plausible explanation.
Delta-8, Delta-10, and HHC Cross-Reactivity
The standard urine immunoassay was designed to detect the metabolite of delta-9-THC, but it does not perfectly distinguish between similar cannabinoid compounds. Research testing six commercially available immunoassay screening kits found that metabolites of delta-8-THC, delta-10-THC, HHC, and even some CBD-derived compounds cross-reacted with the assays, though the degree of cross-reactivity varied depending on the kit and the cutoff used.14Oxford Academic. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays This means that someone using legal hemp-derived delta-8 or HHC products could trigger a positive screening result. Confirmatory testing by mass spectrometry can distinguish between the metabolites, but not all testing programs look for those differences.
If you use any cannabinoid product and face drug testing, you should understand that a “high” carboxy-THC result on a screening immunoassay might partly reflect metabolites of cannabinoids other than conventional delta-9-THC. Whether the testing program will investigate further or simply report a positive depends on the lab and the reason for testing.
Smoked Versus Oral Cannabis and Detection Windows
The method of cannabis use changes the metabolic profile in your urine. When cannabis is eaten rather than smoked, more of the THC passes through the liver before reaching the bloodstream. This first-pass metabolism generates more 11-hydroxy-THC and, downstream, more carboxy-THC relative to smoking. Researchers have found that after oral cannabis consumption, occasional users produced more carboxy-THC–positive urine specimens over a wider detection window compared to the same users after smoking or vaporizing.15Europe PMC. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration For someone trying to estimate how long their levels will remain elevated, edibles are the worst-case scenario: slower absorption, more complete conversion to carboxy-THC, and a longer tail on the detection window.
Carboxy-THC in Blood and Forensic Investigations
Urine is the most common specimen for drug testing, but blood (or plasma) carboxy-THC levels matter in forensic and driving-related investigations. The concentrations involved are far lower than urine values, typically measured in nanograms per milliliter of plasma. Researchers have developed models using the ratio of THC to carboxy-THC in plasma to estimate when cannabis was last used, and these models correctly predicted the time of exposure within the 95% confidence interval in about 90% of samples tested across multiple clinical studies.16Oxford Academic. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)
Postmortem samples add another layer of complexity. A study examining THC and carboxy-THC in postmortem blood found that the ratio of blood-to-serum cannabinoid concentrations in dead individuals differs from the blood-to-plasma ratio established in living people, and the authors specifically recommended against applying a correction factor to try to estimate what plasma levels would have been.17Elsevier. An evaluation of postmortem concentrations of Δ(9)-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol (THCCOOH) In other words, a “high” blood carboxy-THC level in a forensic autopsy case cannot be straightforwardly compared to reference ranges from living subjects.
Carboxy-THC in Hair
Hair testing offers a much longer detection window, potentially months, but the concentrations are measured in picograms per milligram of hair, a thousandfold smaller unit than what you see in urine results. Among documented cannabis users, hair carboxy-THC concentrations ranged from 0.10 to 7.3 pg/mg. Daily users were detected at a significantly higher rate (85%) than non-daily users (52%), but even among known users, more than a third of hair samples had no detectable THC or carboxy-THC at all.18Europe PMC. Cannabinoid concentrations in hair from documented cannabis users
Hair testing also has a well-documented contamination problem. One study found that carboxy-THC appeared in hair segments that had already grown before the participant began taking oral THC, meaning it was deposited externally through sweat and sebum rather than incorporated from the bloodstream during growth.19Scientific Reports. Finding cannabinoids in hair does not prove cannabis consumption For this reason, a “high” carboxy-THC result in hair does not carry the same interpretive confidence as a high urine result. The presence of carboxy-THC in hair is generally considered stronger evidence of actual use than the presence of THC alone, but the finding that it can transfer externally complicates even that assumption.
Neonatal Testing and Meconium
Carboxy-THC testing takes on a different significance in newborn screening. Meconium, the first stool a baby passes, accumulates drug metabolites over roughly the last four months of pregnancy, making it a longer-term marker of prenatal exposure than a newborn’s urine.20Oxford Academic. Simultaneous analysis of the Delta9-THC metabolites 11-nor-9-carboxy-Delta9-THC and 11-hydroxy-Delta9-THC in meconium by GC-MS Umbilical cord tissue is increasingly used as an alternative, but the two matrices are not interchangeable: meconium carboxy-THC concentrations have been measured at roughly 36 times higher than in paired umbilical cord samples.21Oxford University Press. Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters A “high” carboxy-THC result in meconium reflects cumulative fetal exposure over months, while a high result in umbilical cord tissue represents a much shorter window. Comparing numbers between the two without understanding the difference can lead to wildly wrong conclusions about the extent of prenatal cannabis exposure.
The Lab Chemistry Behind the Number
One detail most people never think about is that carboxy-THC in urine exists mostly in a conjugated form, bound to glucuronic acid. The test does not measure this conjugate directly. Instead, the lab must first break the bond through a process called hydrolysis before it can quantify the free carboxy-THC. The method used for hydrolysis can substantially change the result. Alkaline hydrolysis releases carboxy-THC glucuronide most efficiently, while enzymatic hydrolysis works better for THC glucuronide. Using both methods in sequence maximizes the yield for all cannabinoid metabolites and has been shown to nearly double the identification rate in some specimen types.22Europe PMC. Effect of hydrolysis on identifying prenatal cannabis exposure Because hydrolysis can be inconsistent and incomplete, some researchers have advocated for directly measuring both free and glucuronidated carboxy-THC without relying on a hydrolysis step.23Future Science. Rapid quantification of free and glucuronidated THCCOOH in urine using coated well plates and LC-MS/MS analysis
What this means for you is that two labs running the same urine specimen could report somewhat different carboxy-THC numbers depending on their hydrolysis protocol. A result that comes back as 45 ng/mL at one lab might have crossed the 50 ng/mL screening threshold at another. For results near the cutoff, the lab method matters more than most people realize.